Heterocyclically substituted benzoylureas, process for their...

Details Heterocyclically substituted benzoylureas, process for their... Heterocyclically substituted benzoylureas, process for their...

2006-11-21

2006-11-21

Davis, Zinna N. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S210100, C514S241000, C514S242000, C514S317000, C514S364000, C514S381000, C514S383000, C514S394000, C514S406000, C514S408000, C514S461000, C544S180000, C546S192000, C548S131000, C548S253000, C548S255000, C548S262200, C548S304400, C548S375100, C548S567000, C548S950000, C549S499000

Reexamination Certificate

active

07138414

ABSTRACT:
The invention relates to heterocyclically substituted benzoylureas and also to their physiologically tolerated salts and physiologically functional derivatives.Compounds are described of the formula Iwhere the radicals are defined as specified, and also their pharmaceutically acceptable salts and processes for their preparation. The compounds are suitable, for example, for treating type 2 diabetes.

REFERENCES:
patent: 6221633 (2001-04-01), Ertl
patent: 6221897 (2001-04-01), Frick et al.
patent: 6245744 (2001-06-01), Frick et al.
patent: 6342512 (2002-01-01), Kirsch
patent: 10116768 (2002-10-01), None
patent: 10142734 (2003-03-01), None
patent: 0193249 (1986-09-01), None
patent: 0 242 322 (1992-12-01), None
patent: 0 462 884 (1993-06-01), None
patent: WO 97/26265 (1997-07-01), None
patent: WO 97/41097 (1997-11-01), None
patent: WO 98/08871 (1998-03-01), None
patent: WO 99/03861 (1999-01-01), None
patent: WO 99/15525 (1999-04-01), None
patent: WO 00/40569 (2000-07-01), None
patent: WO 00/63208 (2000-10-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 00/64888 (2000-11-01), None
patent: WO 00/66585 (2000-11-01), None
patent: WO 00/71549 (2000-11-01), None
patent: WO 00/78312 (2000-12-01), None
patent: WO 01/09111 (2001-02-01), None
patent: WO 01/83451 (2001-11-01), None
patent: WO 01/85695 (2001-11-01), None
patent: WO 01/91752 (2001-12-01), None
patent: WO 01/94300 (2001-12-01), None
patent: WO 01/94300 (2001-12-01), None
patent: WO 02/096864 (2002-12-01), None
Asakawa A. et al., Cocaine-Amphetamine-Regulated Transcript Influences Energy Metabolism, Anxiety and Gastric Emptying In Mice, Hormones Metabolism Research, (2001), vol. 33, pp. 554-558.
Drueckes P. et al., Photometric Microtiter Assay Of Inorganic Phosphate In The Presence Of Acid-Labile Organic Phosphate, Analytical Biochemistry, (1995), vol. 230, pp. 173-177.
Engers H.D. et al., Kinetic Mechanism Of Phosphorylase a. l. Initial Velocity Studies, Journal Of Biochemistry, (1970), vol. 48, pp. 746-754.
Okada Hiroshi et al., Synthesis And Antitumor Activities Of Prodrugs Of Benzoylphenylureas, Chemical And Pharmaceuticals Bulletin, (1994), vol. 42, No. 1, pp. 57-61.
Salvador Javier et al., Perspectives In The Therapeutic Use Of Leptin, Expert Opinion On Pharmacotherapy, (2001), vol. 2, No. 10, pp. 1615-1622.
Tyle Praveen, Iontophoretic Devices For Drug Delivery, Pharmaceutical Research, (1986), vol. 3, No. 6, pp. 318-326.
Zunft H.J.F. et al., Carob Pulp Preparation For Treatment Of Hypercholesterolemia, Advances In Therapy, (2001), vol. 18, No. 5, pp. 231-236.

Affiliated with

Also associated with

Rating

Heterocyclically substituted benzoylureas, process for their... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclically substituted benzoylureas, process for their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclically substituted benzoylureas, process for their... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3655917